CHARLOTTE, N.C. — In a Healio video exclusive, Eamonn Quigley, MD, reported increased compliance to an orally ingested vibrating capsule predicted positive outcomes among patients with chronic idiopathic constipation.In an 8 week, randomized, double-blind phase 3 trial, Quigley, a gastroenterology specialist at Houston Methodist, and colleagues evaluated the impact of compliance on the efficacy of the vibrating capsule. Patients with chronic idiopathic constipation (CIC) received either orally ingested vibrating capsules (n = 163) or placebo (n = 149).Results showed those who compliedRead More
- (305) 687-1367
- info@flgastro.org
- Mon - Fri: 9:00am - 5:00pm